142 related articles for article (PubMed ID: 24106677)
1. Intranasal delivery of chitosan nanoparticles for migraine therapy.
Gulati N; Nagaich U; Saraf SA
Sci Pharm; 2013; 81(3):843-54. PubMed ID: 24106677
[TBL] [Abstract][Full Text] [Related]
2. Intranasal drug delivery of sumatriptan succinate-loaded polymeric solid lipid nanoparticles for brain targeting.
Yadav RK; Shah K; Dewangan HK
Drug Dev Ind Pharm; 2022 Jan; 48(1):21-28. PubMed ID: 35703403
[TBL] [Abstract][Full Text] [Related]
3. Ionically Cross-Linked Chitosan Nanoparticles for Sustained Delivery of Docetaxel: Fabrication, Post-Formulation and Acute Oral Toxicity Evaluation.
Mahmood MA; Madni A; Rehman M; Rahim MA; Jabar A
Int J Nanomedicine; 2019; 14():10035-10046. PubMed ID: 31908458
[TBL] [Abstract][Full Text] [Related]
4. Development and optimization of in-situ gel containing chitosan nanoparticles for possible nose-to-brain delivery of vinpocetine.
Hard SAAA; Shivakumar HN; Redhwan MAM
Int J Biol Macromol; 2023 Dec; 253(Pt 6):127217. PubMed ID: 37793522
[TBL] [Abstract][Full Text] [Related]
5. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
[No Abstract] [Full Text] [Related]
6. Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson's Disease.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Curr Drug Discov Technol; 2019; 16(4):417-425. PubMed ID: 29669501
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of chitosan nanoparticles containing an indanonic tricyclic spiroisoxazoline derivative using ion-gelation method: an
Abolhasani A; Heidari F; Abolhasani H
Drug Dev Ind Pharm; 2020 Oct; 46(10):1604-1612. PubMed ID: 32812474
[TBL] [Abstract][Full Text] [Related]
8. Sumatriptan succinate loaded chitosan solid lipid nanoparticles for enhanced anti-migraine potential.
Hansraj GP; Singh SK; Kumar P
Int J Biol Macromol; 2015 Nov; 81():467-76. PubMed ID: 26299709
[TBL] [Abstract][Full Text] [Related]
9. Silk fibroin hydrogel/dexamethasone sodium phosphate loaded chitosan nanoparticles as a potential drug delivery system.
Akrami-Hasan-Kohal M; Eskandari M; Solouk A
Colloids Surf B Biointerfaces; 2021 Sep; 205():111892. PubMed ID: 34107443
[TBL] [Abstract][Full Text] [Related]
10. Preparation and Characterization of Chitosan Nanoparticles for Zidovudine Nasal Delivery.
Barbi Mda S; Carvalho FC; Kiill CP; Barud Hda S; Santagneli SH; Ribeiro SJ; GremiĆ£o MP
J Nanosci Nanotechnol; 2015 Jan; 15(1):865-74. PubMed ID: 26328451
[TBL] [Abstract][Full Text] [Related]
11. Intranasal delivery of tapentadol hydrochloride-loaded chitosan nanoparticles: formulation, characterisation and its in vivo evaluation.
Javia A; Thakkar H
J Microencapsul; 2017 Nov; 34(7):644-658. PubMed ID: 28862072
[TBL] [Abstract][Full Text] [Related]
12. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
Saini D; Fazil M; Ali MM; Baboota S; Ali J
Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026
[TBL] [Abstract][Full Text] [Related]
13. Fabrication, Optimization, and Evaluation of Rotigotine-Loaded Chitosan Nanoparticles for Nose-To-Brain Delivery.
Tzeyung AS; Md S; Bhattamisra SK; Madheswaran T; Alhakamy NA; Aldawsari HM; Radhakrishnan AK
Pharmaceutics; 2019 Jan; 11(1):. PubMed ID: 30634665
[TBL] [Abstract][Full Text] [Related]
14. Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study.
Delan WK; Zakaria M; Elsaadany B; ElMeshad AN; Mamdouh W; Fares AR
Int J Pharm; 2020 Mar; 577():119038. PubMed ID: 31953085
[TBL] [Abstract][Full Text] [Related]
15. Development and Evaluation of Diclofenac Sodium Loaded-N-Trimethyl Chitosan Nanoparticles for Ophthalmic Use.
Asasutjarit R; Theerachayanan T; Kewsuwan P; Veeranodha S; Fuongfuchat A; Ritthidej GC
AAPS PharmSciTech; 2015 Oct; 16(5):1013-24. PubMed ID: 25609376
[TBL] [Abstract][Full Text] [Related]
16. Interfacial Phenomenon Based Biocompatible Alginate-Chitosan Nanoparticles Containing Isoniazid and Pyrazinamide.
Kushwaha K; Dwivedi H
Pharm Nanotechnol; 2018; 6(3):209-217. PubMed ID: 29938624
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of pentamidine-loaded chitosan nanoparticles as a novel drug delivery system for Leishmania tropica.
Khan RU; Khan M; Sohail A; Ullah R; Iqbal A; Ahmad B; Khan IU; Tariq A; Ahmad M; Said A; Ullah S; Ali A; Rahman MU; Zaman A; Bilal H
Trop Biomed; 2022 Dec; 39(4):511-517. PubMed ID: 36602209
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamic and in vitro evaluation of chitosan/tripolyphosphate nanoparticles as an insulin delivery system at two different pH values.
Nejabat M; Kalani MR; Nejabat M; Hadizadeh F
J Biomol Struct Dyn; 2022; 40(20):10153-10161. PubMed ID: 34154515
[TBL] [Abstract][Full Text] [Related]
19. Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane.
Singh KH; Shinde UA
Pharmazie; 2011 Aug; 66(8):594-9. PubMed ID: 21901982
[TBL] [Abstract][Full Text] [Related]
20. Study of 5-Fluorouracil Loaded Chitosan Nanoparticles for Treatment of Skin Cancer.
Patel G; Yadav BKN
Recent Pat Nanotechnol; 2020; 14(3):210-224. PubMed ID: 31267881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]